Abstract
Elevated expression of HMGA1 and HMGA2 proteins is correlated with a highly malignant phenotype in several human tumors. We previously demonstrated that the block of HMGA2 protein synthesis prevented rat thyroid cell transformation by murine retroviruses. Suppression of HMGA2 synthesis was associated with lack of induction of HMGA1 proteins suggesting that both HMGA1 and HMGA2 play a role in the process of neoplastic transformation. To determine the role of the HMGA1 gene in thyroid cell transformation, we blocked HMGA1 protein synthesis by an antisense methodology. Here we report that transfection of an HMGA1 cDNA antisense construct into a normal rat thyroid cell line (FRTL-5 Cl2), followed by infection with Kirsten murine sarcoma virus (KiMSV), generated a transformed cell line that expresses high levels of the v-ras-Ki oncogene and that does not require thyroid-stimulating hormones for growth. However, this cell line does not show the malignant phenotype, i.e., it neither grows in soft agar nor induces tumors after injection in athymic mice. Moreover, the lack of the neoplastic phenotype in the virus-infected thyroid cells carrying the HMGA1 antisense construct correlates with the absence of induction of AP-1 transcriptional activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abe N, Watanabe T, Sugiyama M, Chiappetta G, Fusco A, Atomi Y . 1999 Cancer Res. 59: 1169–1174
Abe N, Watanabe T, Masaki T, Mori T, Sugiyama M, Uchimura H, Fujioka Y, Chiappetta G, Fusco A, Atomi Y . 2000 Cancer Res. 60: 3117–3122
Ambesi-Impiombato FS, Parks LAM, Coon HG . 1980 Proc. Natl. Acad. Sci. USA 77: 3455–3459
Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M, Waldmann TA, Azimi N, Croce CM, Fusco A . 2001 Proc. Natl. Acad. Sci. USA 98: 7970–7975
Bandiera A, Bonifacio D, Manfioletti G, Mantovani F, Rustighi A, Zanconati F, Fusco A, Di Bonito L, Giancotti V . 1998 Cancer Res. 58: 426–431
Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A . 1995 Mol. Cell. Biol. 15: 1545–1553
Berlingieri MT, Akamizu T, Fusco A, Grieco M, Colletta G, Cirafici AM, Ikuyama S, Kohn LD, Vecchio G . 1990 Biochem. Biophys. Res. Commun. 173: 172–178
Briggs MR, Kadonaga JT, Bell SP, Tjian R . 1986 Science 234: 47–52
Bustin M . 1999 Mol. Cell. Biol. 19: 5237–5246
Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai FM, Fidanza V, Giancotti V, Santoro M, Simeone A, Fusco A . 1996 Oncogene 13: 2439–2446
Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A . 1995 Oncogene 10: 1307–1314
Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martines-Tello FJ, Pentimalli F, De Nigris F, Mastro A, Botti G, Fedele M, Bergen N, Santoro M, Giancotti V, Fusco A . 1998 Cancer Res. 58: 4193–4198
Chiappetta G, Manfioletti G, Pentimalli F, Abe N, Di Bonito M, Vento MT, Giuliano A, Fedele M, Viglietto G, Santoro M, Watanabe T, Giancotti V, Fusco A . 2001 Int. J. Cancer 91: 147–151
Cohen DR, Curran T . 1988 Mol. Cell. Biol. 8: 2063–2069
Di Lauro R, Obici S, Acquaviva A, Alvino C . 1982 Gene 19: 117–125
Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassimi A, Santoro M, Giancotti V, Fusco A . 1996 Cancer Res. 56: 1896–1901
Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto AJP, Parlow AF, Visone R, Pierantoni GM, Outwater F, Santoro M, Croce CM, Fusco A . 2002 Oncogene 21: in press
Fedele M, Pierantoni GM, Berlingieri MT, Battista S, Baldassarre G, Munshi N, Dentice M, Thanos D, Santoro M, Viglietto G, Fusco A . 2001a Cancer Res. 61: 4583–4590
Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A . 2001b Carcinogenesis 22: 101–109
Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G . 1987 Mol. Cell. Biol. 7: 3365–3370
Gack S, Vallon R, Schaper J, Ruther U, Angel P . 1994 J. Biol. Chem. 269: 363–369
Giancotti V, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Crane-Robinson C . 1985 Cancer Res. 45: 6051–6057
Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Philp R, Crane-Robinson C, Nicolas RH, Wright CA, Goodwin GH . 1987 EMBO J. 6: 1981–1987
Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH . 1989 Exp. Cell. Res. 184: 538–545
Graham FL, Van der Eb AJ . 1973 Virology 52: 456–467
Johnson KR, Lehn DA, Reeves R . 1989 Mol. Cell. Biol. 9: 2114–2123
Lee W, Mitchell P, Tjian R . 1987 Cell 49: 741–752
Lovell-Badge R . 1995 Nature 376: 725–726
Macpherson I, Montagnier I . 1964 Virology 23: 291–294
Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, Goodwin GH . 1991 Nucleic Acids Res. 19: 6793–6797
Melillo RM, Pierantoni GM, Scala S, Battista S, Fedele M, Stella A, De Biasio MC, Chiappetta G, Fidanza V, Condorelli G, Santoro M, Croce CM, Viglietto G, Fusco A . 2001 Mol. Cell. Biol. 21: 2485–2495
Reeves R, Edberg DD, Li Y . 2001 Mol. Cell. Biol. 21: 575–594
Ryder K, Lau LF, Nathans D . 1988 Proc. Natl. Acad. Sci. USA 85: 1487–1491
Sambrook J, Fritsch EF, Maniatis T . 1989 Molecular Cloning: A Laboratory Manual Cold Spring Harbor (NY) Second Edition New York: Cold Spring Harbor Laboratory Press
Scala S, Portella G, Fedele M, Chiappetta G, Fusco A . 2000 Proc. Natl. Acad. Sci. USA 97: 4256–4261
Scala S, Portella G, Vitagliano D, Ledent C, Chiappetta G, Giancotti V, Dumont J, Fusco A . 2001 Carcinogenesis 22: 251–256
Tamimi Y, van der Poel HG, Denyn MM, Umbas R, Karthaus HFM, Debruyne FMJ, Shalken JA . 1993 Cancer Res. 53: 5512–5516
Tokunaga K, Nakamura Y, Sakataka K, Fujimari K, Ohkuba M, Sawada K, Sakiyama S . 1987 Cancer Res. 21: 5616–5619
Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P . 1997 EMBO J. 16: 5310–5321
Wood LJ, Mukherjee M, Dolde CE, Xu Y, Maher JF, Bunton TE, Williams JB, Resar LM . 2000a Mol. Cell. Biol. 20: 5490–5502
Wood LJ, Maher JF, Bunton TE, Resar LM . 2000b Cancer Res. 60: 4256–4261
Zannini MS, Francis-Lang H, Plachov D, Di Lauro R . 1992 Mol. Cell. Biol. 12: 4230–4241
Zhou X, Benson KF, Ashar HR, Chada K . 1995 Nature (Lond.) 376: 771–774
Acknowledgements
This work was supported by grants from ‘Progetto Speciale Oncosoppressori’ AIRC, the Progetto Finalizzato ‘Biotecnologie’ of the Consiglio Nazionale delle Ricerche (CNR), CNE Progetto ‘5%’, the MURST project ‘Terapie antineoplastiche innovative’, the ‘Ministero della Sanità’, the Università degli Studi di Trieste (60%), the Ministero della Ricerca Scientifica e Tecnologica (40%). We are grateful to Jean Ann Gilder for text editing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berlingieri, M., Pierantoni, G., Giancotti, V. et al. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 21, 2971–2980 (2002). https://doi.org/10.1038/sj.onc.1205368
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205368
Keywords
This article is cited by
-
Interplay between HMGA and TP53 in cell cycle control along tumor progression
Cellular and Molecular Life Sciences (2021)
-
High mobility group A1 protein modulates autophagy in cancer cells
Cell Death & Differentiation (2017)
-
HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
Scientific Reports (2017)
-
HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism
Scientific Reports (2016)
-
A Comprehensive Safety Evaluation of Trabectedin and Drug–Drug Interactions of Trabectedin-Based Combinations
BioDrugs (2014)